Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2016. Stockholm: ECDC; 2018

Copy citation to clipboard

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Read more

Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Related updates on Neisseria gonorrhoeae


Trends and data on gonorrhoea in the EU/EEA, 2016

presentation -


Gonorrhoea - Annual Epidemiological Report for 2016

surveillance report -


Understanding drug-resistant gonorrhoea: an ECDC whole genome sequencing study

news -


Molecular typing of Neisseria gonorrhoeae – a study of 2013 isolates

technical report -


ECDC: first detected cases of extensively drug-resistant gonorrhoea threaten future treatment

news -